The impact of glycogen synthase kinase 3β gene on psychotic mania in bipolar disorder patients

Youn Jung Lee, Yong Ku Kim

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: The aim of this study was to examine the relationships between glycogen synthase 3β gene polymorphisms and bipolar I disorder, manic in a Korean sample. Methods: Patients with bipolar disorder (n = 118) and a control group (n = 158) were assessed by genotyping for GSK3β single nucleotide polymorphisms (SNPs) - 1727A/T and - 50C/T. The patients were divided into two groups according to the presence of psychotic symptoms (psychotic mania, n = 92; non-psychotic mania, n = 26) and also divided based on gender and age of onset. The severity of symptoms was measured using the Young Mania Rating Scale (YMRS) and the Brief Psychiatric Rating Scale (BPRS). Results: There were no significant differences in the genotype distributions or allelic frequencies of GSK3β polymorphisms and gender between patients with bipolar disorder and a normal control group. According to haplotype analysis, there was no association between these two groups. However, analysis of the age of onset of bipolar disorder revealed significant differences in genotype and allele distributions among the patients. Patients who were homozygous for the wild-type variant (TT) had an older age of onset than carriers of the mutant allele (A/A: 27.4 ± 9.1; A/T: 30.1 ± 11.8; T/T: 42.3 ± 19.9; p = 0.034). We detected differences in allele frequencies of the GSK3β - 1727A/T polymorphism between the psychotic mania group and the non-psychotic mania group. Conclusion: This study suggests that GSK3β polymorphisms are not associated with bipolar disorder. However, the GSK3β SNP - 1727A/T is associated with age of onset and presence of psychotic symptoms in bipolar disorder.

Original languageEnglish
Pages (from-to)1303-1308
Number of pages6
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume35
Issue number5
DOIs
Publication statusPublished - 2011 Jul 1

Fingerprint

Glycogen Synthase Kinase 3
Bipolar Disorder
Genes
Age of Onset
Single Nucleotide Polymorphism
Alleles
Genotype
Brief Psychiatric Rating Scale
Glycogen Synthase
Control Groups
Gene Frequency
Haplotypes

Keywords

  • -1727A/T
  • -50C/T
  • Bipolar disorder
  • Glycogen synthase kinase 3β (GSK3β) gene polymorphism

ASJC Scopus subject areas

  • Biological Psychiatry
  • Pharmacology

Cite this

The impact of glycogen synthase kinase 3β gene on psychotic mania in bipolar disorder patients. / Lee, Youn Jung; Kim, Yong Ku.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 35, No. 5, 01.07.2011, p. 1303-1308.

Research output: Contribution to journalArticle

@article{901bfc59fdf54ec3b2d0c05d8cca9789,
title = "The impact of glycogen synthase kinase 3β gene on psychotic mania in bipolar disorder patients",
abstract = "Objective: The aim of this study was to examine the relationships between glycogen synthase 3β gene polymorphisms and bipolar I disorder, manic in a Korean sample. Methods: Patients with bipolar disorder (n = 118) and a control group (n = 158) were assessed by genotyping for GSK3β single nucleotide polymorphisms (SNPs) - 1727A/T and - 50C/T. The patients were divided into two groups according to the presence of psychotic symptoms (psychotic mania, n = 92; non-psychotic mania, n = 26) and also divided based on gender and age of onset. The severity of symptoms was measured using the Young Mania Rating Scale (YMRS) and the Brief Psychiatric Rating Scale (BPRS). Results: There were no significant differences in the genotype distributions or allelic frequencies of GSK3β polymorphisms and gender between patients with bipolar disorder and a normal control group. According to haplotype analysis, there was no association between these two groups. However, analysis of the age of onset of bipolar disorder revealed significant differences in genotype and allele distributions among the patients. Patients who were homozygous for the wild-type variant (TT) had an older age of onset than carriers of the mutant allele (A/A: 27.4 ± 9.1; A/T: 30.1 ± 11.8; T/T: 42.3 ± 19.9; p = 0.034). We detected differences in allele frequencies of the GSK3β - 1727A/T polymorphism between the psychotic mania group and the non-psychotic mania group. Conclusion: This study suggests that GSK3β polymorphisms are not associated with bipolar disorder. However, the GSK3β SNP - 1727A/T is associated with age of onset and presence of psychotic symptoms in bipolar disorder.",
keywords = "-1727A/T, -50C/T, Bipolar disorder, Glycogen synthase kinase 3β (GSK3β) gene polymorphism",
author = "Lee, {Youn Jung} and Kim, {Yong Ku}",
year = "2011",
month = "7",
day = "1",
doi = "10.1016/j.pnpbp.2011.04.006",
language = "English",
volume = "35",
pages = "1303--1308",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - The impact of glycogen synthase kinase 3β gene on psychotic mania in bipolar disorder patients

AU - Lee, Youn Jung

AU - Kim, Yong Ku

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Objective: The aim of this study was to examine the relationships between glycogen synthase 3β gene polymorphisms and bipolar I disorder, manic in a Korean sample. Methods: Patients with bipolar disorder (n = 118) and a control group (n = 158) were assessed by genotyping for GSK3β single nucleotide polymorphisms (SNPs) - 1727A/T and - 50C/T. The patients were divided into two groups according to the presence of psychotic symptoms (psychotic mania, n = 92; non-psychotic mania, n = 26) and also divided based on gender and age of onset. The severity of symptoms was measured using the Young Mania Rating Scale (YMRS) and the Brief Psychiatric Rating Scale (BPRS). Results: There were no significant differences in the genotype distributions or allelic frequencies of GSK3β polymorphisms and gender between patients with bipolar disorder and a normal control group. According to haplotype analysis, there was no association between these two groups. However, analysis of the age of onset of bipolar disorder revealed significant differences in genotype and allele distributions among the patients. Patients who were homozygous for the wild-type variant (TT) had an older age of onset than carriers of the mutant allele (A/A: 27.4 ± 9.1; A/T: 30.1 ± 11.8; T/T: 42.3 ± 19.9; p = 0.034). We detected differences in allele frequencies of the GSK3β - 1727A/T polymorphism between the psychotic mania group and the non-psychotic mania group. Conclusion: This study suggests that GSK3β polymorphisms are not associated with bipolar disorder. However, the GSK3β SNP - 1727A/T is associated with age of onset and presence of psychotic symptoms in bipolar disorder.

AB - Objective: The aim of this study was to examine the relationships between glycogen synthase 3β gene polymorphisms and bipolar I disorder, manic in a Korean sample. Methods: Patients with bipolar disorder (n = 118) and a control group (n = 158) were assessed by genotyping for GSK3β single nucleotide polymorphisms (SNPs) - 1727A/T and - 50C/T. The patients were divided into two groups according to the presence of psychotic symptoms (psychotic mania, n = 92; non-psychotic mania, n = 26) and also divided based on gender and age of onset. The severity of symptoms was measured using the Young Mania Rating Scale (YMRS) and the Brief Psychiatric Rating Scale (BPRS). Results: There were no significant differences in the genotype distributions or allelic frequencies of GSK3β polymorphisms and gender between patients with bipolar disorder and a normal control group. According to haplotype analysis, there was no association between these two groups. However, analysis of the age of onset of bipolar disorder revealed significant differences in genotype and allele distributions among the patients. Patients who were homozygous for the wild-type variant (TT) had an older age of onset than carriers of the mutant allele (A/A: 27.4 ± 9.1; A/T: 30.1 ± 11.8; T/T: 42.3 ± 19.9; p = 0.034). We detected differences in allele frequencies of the GSK3β - 1727A/T polymorphism between the psychotic mania group and the non-psychotic mania group. Conclusion: This study suggests that GSK3β polymorphisms are not associated with bipolar disorder. However, the GSK3β SNP - 1727A/T is associated with age of onset and presence of psychotic symptoms in bipolar disorder.

KW - -1727A/T

KW - -50C/T

KW - Bipolar disorder

KW - Glycogen synthase kinase 3β (GSK3β) gene polymorphism

UR - http://www.scopus.com/inward/record.url?scp=79957869681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957869681&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2011.04.006

DO - 10.1016/j.pnpbp.2011.04.006

M3 - Article

C2 - 21549170

AN - SCOPUS:79957869681

VL - 35

SP - 1303

EP - 1308

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 5

ER -